DOMAIN Therapeutics
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
5
Funding Rounds
$98.6m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa**** Ne****** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa**** Ne****** | - | - | |
| Em****** Fi******** | - | - | - |
| Sy**** Ry******** | - | - | - |
| Yo***** L. Be***** | - | - | - |
| Ro***** De Po*** | - | - | - |
| La****** Ru***** | - | - | - |
| Ja*** Hu*** | - | - |
Funding
Funding series
Funding Series Analysis
The company DOMAIN Therapeutics has raised a total of $56.56m in funding over 5 rounds.
Key Insights:
- DOMAIN Therapeutics Series A round, May 2022: $42m
- DOMAIN Therapeutics , May 2019: $3.9m
- DOMAIN Therapeutics funding round, July 2012: $2.46m
- DOMAIN Therapeutics Series C round Funding Round 2006: $8.2m
- Domain Therapeutics 2022 Funding Round: $42m
DOMAIN Therapeutics Series A round, May 2022
$42m
DOMAIN Therapeutics , May 2019
$3.9m
DOMAIN Therapeutics funding round, July 2012
$2.46m
DOMAIN Therapeutics Series C round Funding Round 2006
$8.2m
Domain Therapeutics 2022 Funding Round
$42m
Industries
DOMAIN Therapeutics is active in the following industries:
- Therapeutics
- Biosensor
- Biomedical engineering
- Technology
- Biology
- Biotechnology
- Engineering
- Manufacturing
- Pharmaceutical industry
- Health technology